709 related articles for article (PubMed ID: 27619682)
21. Increased tumor-infiltrating CD8(+)Foxp3(+) T lymphocytes are associated with tumor progression in human gastric cancer.
Peng LS; Zhuang Y; Shi Y; Zhao YL; Wang TT; Chen N; Cheng P; Liu T; Liu XF; Zhang JY; Zuo QF; Mao XH; Guo G; Lu DS; Yu PW; Zou QM
Cancer Immunol Immunother; 2012 Nov; 61(11):2183-92. PubMed ID: 22729557
[TBL] [Abstract][Full Text] [Related]
22. CD4+CD25+Foxp3+IFN-γ+ human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically.
Daniel V; Sadeghi M; Wang H; Opelz G
Hum Immunol; 2011 Sep; 72(9):699-707. PubMed ID: 21664396
[TBL] [Abstract][Full Text] [Related]
23. Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis.
Han D; Wang C; Lou W; Gu Y; Wang Y; Zhang L
Clin Immunol; 2010 Aug; 136(2):292-301. PubMed ID: 20403730
[TBL] [Abstract][Full Text] [Related]
24. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis.
Ferri S; Longhi MS; De Molo C; Lalanne C; Muratori P; Granito A; Hussain MJ; Ma Y; Lenzi M; Mieli-Vergani G; Bianchi FB; Vergani D; Muratori L
Hepatology; 2010 Sep; 52(3):999-1007. PubMed ID: 20683931
[TBL] [Abstract][Full Text] [Related]
25. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC
J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337
[TBL] [Abstract][Full Text] [Related]
26. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
27. Significance of TIM-3 expression by CD4
Shariati S; Ghods A; Zohouri M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
Mol Immunol; 2020 Dec; 128():47-54. PubMed ID: 33068833
[TBL] [Abstract][Full Text] [Related]
28. Expansion of FOXP3-positive CD4+CD25+ T cells associated with disease activity in atopic dermatitis.
Ito Y; Adachi Y; Makino T; Higashiyama H; Fuchizawa T; Shimizu T; Miyawaki T
Ann Allergy Asthma Immunol; 2009 Aug; 103(2):160-5. PubMed ID: 19739430
[TBL] [Abstract][Full Text] [Related]
29. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
[TBL] [Abstract][Full Text] [Related]
30. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
[TBL] [Abstract][Full Text] [Related]
31. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
[TBL] [Abstract][Full Text] [Related]
32. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease.
Zanzi D; Stefanile R; Santagata S; Iaffaldano L; Iaquinto G; Giardullo N; Lania G; Vigliano I; Vera AR; Ferrara K; Auricchio S; Troncone R; Mazzarella G
Am J Gastroenterol; 2011 Jul; 106(7):1308-17. PubMed ID: 21468011
[TBL] [Abstract][Full Text] [Related]
33. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.
Di Caro V; D'Anneo A; Phillips B; Engman C; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
Clin Exp Immunol; 2011 Jul; 165(1):60-76. PubMed ID: 21413939
[TBL] [Abstract][Full Text] [Related]
35. Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer.
Maruyama T; Kono K; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Izawa S; Fujii H
Cancer Sci; 2010 Sep; 101(9):1947-54. PubMed ID: 20550524
[TBL] [Abstract][Full Text] [Related]
36. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
[TBL] [Abstract][Full Text] [Related]
37. Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases.
Bossowski A; Moniuszko M; Dąbrowska M; Sawicka B; Rusak M; Jeznach M; Wójtowicz J; Bodzenta-Lukaszyk A; Bossowska A
Autoimmunity; 2013 May; 46(3):222-30. PubMed ID: 23249428
[TBL] [Abstract][Full Text] [Related]
38. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N
Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
[TBL] [Abstract][Full Text] [Related]
39. IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
Müller M; Herrath J; Malmström V
Clin Exp Immunol; 2015 Oct; 182(1):90-100. PubMed ID: 26076982
[TBL] [Abstract][Full Text] [Related]
40. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
